-

Leading CDMO Adopts ValGenesis to Support Robotic Manufacturing Expansion

SANTA CLARA, Calif.--(BUSINESS WIRE)--ValGenesis, Inc. today announced that a leading fill-finish contract development and manufacturing organization (CDMO) specializing in sterile filling has adopted ValGenesis to modernize logbook management across its state-of-the-art manufacturing facilities.

The application scales to support thousands of users across multiple global sites and offers offline functionality for secure, controlled environments, ensuring continuous, compliant operations as the company grows.

Share

As the company expanded operations to include advanced robotic manufacturing lines and increasingly sophisticated equipment, managing hundreds of paper logbooks became inefficient and difficult to scale. By implementing ValGenesis, the company has eliminated the limitations of manual record-keeping, enabling real-time data capture, automated compliance checks, and seamless traceability.

The cloud-based electronic logbook application is designed to meet the rigorous requirements of the life sciences industry. It enables users to digitally capture, track, and maintain GMP logbooks across multiple devices. The application scales to support thousands of users across multiple global sites and offers offline functionality for secure, controlled environments, ensuring continuous, compliant operations as the company grows.

By strengthening its quality management system and optimizing resource utilization, the company ensures that collected data adheres to ALCOA+ data integrity principles while accelerating time to market for its clients.

“We’re excited to support this customer in their digital transformation journey,” said Steve Reynolds, chief revenue officer at ValGenesis. “By replacing paper-based logbooks with ValGenesis, the company is strengthening compliance, improving operational efficiency, and ensuring scalability as it continues to grow and adopt advanced manufacturing technologies.”

About ValGenesis Inc.

ValGenesis, Inc. is the global leader in enterprise digital validation. Serving the life sciences industry for nearly two decades, ValGenesis enables companies to digitize their commissioning, qualification, and validation processes through its AI-enabled ValGenesis Smart GxP™ Platform, which includes solutions for risk management, cleaning validation, continued process verification, and CMC development. ValGenesis helps customers worldwide reduce costs, improve compliance, and accelerate innovation. For more information, visit https://www.valgenesis.com/.

Contacts

Further information

Althea D'Sylva, ValGenesis Communications, +1 510-445-0505 Ex.1026 althea.dsylva@valgenesis.com

ValGenesis, Inc.


Release Versions

Contacts

Further information

Althea D'Sylva, ValGenesis Communications, +1 510-445-0505 Ex.1026 althea.dsylva@valgenesis.com

Social Media Profiles
More News From ValGenesis, Inc.

ValGenesis to Showcase Process Lifecycle Suite at BioProcessing Summit Europe 2026

SANTA CLARA, Calif.--(BUSINESS WIRE)--ValGenesis Inc., the global leader in digital validation lifecycle management, will showcase its Process Lifecycle Suite, part of the ValGenesis Smart GxP™ platform, at BioProcessing Summit Europe 2026, taking place March 10-12 in Barcelona. The event brings together bioprocessing innovators, scientists, and decision-makers shaping the future of modern biomanufacturing. Many pharmaceutical and biotechnology companies, including cell and gene therapy develop...

ValGenesis to Exhibit Smart GxP™ at 2026 ISPE Europe Annual Conference

SANTA CLARA, Calif.--(BUSINESS WIRE)--ValGenesis Inc., the global leader in digital validation lifecycle management, will exhibit its Smart GxP™ platform at the ISPE Europe Annual Conference, April 20-22, in Copenhagen, Denmark. As pharmaceutical and biotechnology manufacturers navigate increasing regulatory expectations, operational complexity, and the integration of artificial intelligence into GxP environments, ValGenesis product specialists will be on-site to connect with pharmaceutical eng...

ValGenesis to Join Industry Peers at 2026 ISPE San Francisco Vendor Night

SANTA CLARA, Calif.--(BUSINESS WIRE)--ValGenesis Inc., the global leader in enterprise digital validation lifecycle management, will attend the 33rd Annual ISPE San Francisco Vendor Night on March 19, 2026, at Oracle Park in San Francisco. Vendor Night is one of the Bay Area’s largest gatherings for professionals across the biotechnology, pharmaceutical, and medical device manufacturing sectors, drawing nearly 2,000 attendees, including engineers, consultants, government agencies, and academic...
Back to Newsroom